The core activity of ATANIS Biotech AG is the development of new diagnostic procedures and therapies for allergies, particularly the development of FAST-PASE, an innovative diagnostic tool. The company focuses on researching and developing solutions for the diagnosis and treatment of allergies, aiming to improve the quality of life for patients.
AI-generated
Offering
Products & services
Industry:
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Blood-based allergy diagnostics without allergen exposure, with reliable analysis of food allergies and other allergens; provides digital reports for physicians.
Research partnering and assay development
Collaboration with academic groups, hospitals and industry; experiment design, assay customisation, data analysis and support for publications and clinical studies.
Publications and scientific evidence
Published research papers and clinical data on FAST-PASE®, in particular on food allergies, mast cell assays and diagnostic validation.